Hear From Our Experts on Improving Clinical Trial Enrollment Diversity
In our latest podcast, BBK's Justin Jones and Gaby Grekin discuss strategies and insights that clinical trial sponsors can leverage to make their studies more diverse and inclusive.
Read More
Topics:
Media,
Research,
Diversity,
Inclusion,
Gaby Grekin,
Strategy,
Justin Jones,
The Conference Forum,
Equity,
Podcast
Introducing a New Approach to Clinical Trial Recruitment & Engagement
Our hybrid approach to clinical trial recruitment and engagement provides sponsors with the flexibility and agility they need whether they are conducting a traditional site-based trial, hybrid trial, or decentralized trial.
Read More
Topics:
TrialCentralNet,
Decentralized Clinical Trials,
Decentralized Solutions,
Hybrid Clinical Trials,
Hybrid,
TCN
Pharma15 Live!
Facilitating the Journey from Patient to Study Participant
The Impact of Dynamic Referral Processing
Matt Kibby and Aaron Fleishman return to the Pharma15 Live! stage to discuss BBK's dynamic referral processing service and how it improves and accelerates the patient enrollment process.
"Our process benefits both patients and sites alike. It unburdens the study staff, creating a better experience for them, while also ensuring patients are responded to more quickly and with better care so their journey is a positive one."
-Matt Kibby, President, Chief Strategy Officer, BBK Worldwide

Read More
Topics:
Pharma15 Live!,
Call Centers,
Matt Kibby,
Aaron Fleishman,
Hybrid Clinical Trials,
Dynamic Referral Processing,
Secondary Prescreening
Blueprint for Success: Proven Strategies for Patient Engagement
Download our blueprint for patient engagement and get a compilation of ideas and proven strategies to help you and your clinical trial team create a successful patient engagement program.

Read More
Topics:
Patient Engagement,
Aaron Fleishman,
Free Download,
Hybrid
Words Matter: The Hybrid Lexicon
In a time of confusing terminology, one thing is clear: what the industry used to consider exceptional is now considered essential.
Hybrid. Decentralized. Remote. Digital. Virtual. Companies use these terms interchangeably. There is inconsistency, over-hyping, over-promising, confusion, and a notable lack of substance. To be honest, it’s a bit like the Wild West out there.
Read More
Topics:
Digital,
Virtual,
Decentralized Clinical Trials,
Hybrid Clinical Trials,
Remote
New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.
Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial models to hybrid models with confidence.
DOWNLOAD NOW
Read More
Topics:
Most Viewed,
Study Voices,
Aaron Fleishman,
International Clinical Trials,
Surveys,
Hybrid Clinical Trials
For two physically identical people, my sister and I have polar opposite cognitive styles.
It’s the classic case of right versus left brain. For example, I followed my creative, right-brained spirit straight into professional writing. Meanwhile, my sister channeled her analytical, left-brained energy to study…well, the brain.
Read More
Topics:
BBK Worldwide,
Clinical Trial Enrollment,
Clinical Trial Engagement
A Diversified Outreach Strategy
Is Key to Clinical Trial Inclusivity
New Infographic Available for Download
Many clinical trial sponsors are seeking ways to enable hybrid study designs with ease and confidence. Our new infographic follows the patient's journey from consideration to enrollment to engagement throughout the study life cycle, with information to help sponsors create a more diverse and inclusive participation environment.
Read More
Topics:
Most Viewed,
Study Voices,
Infographics,
Underserved Populations,
Diversity,
Inclusion,
Free Download
We are all hoping that 2022 will be a better year for the world, one where the impact of the pandemic truly begins to subside for everyone around the globe. That said, it is a basic truth that every challenge presents some opportunity, and the impact of COVID-19 on the clinical research and development industry has been no exception.
Read More
Topics:
Rob Laurens,
Decentralized Clinical Trials,
Hybrid Clinical Trials,
Crystal Ball,
Concierge,
Site Centricity
We are very excited to kick off the new year with the announcement that we have been acquired by Publicis Health, the healthcare communications leader that transforms healthcare marketing and communications into healthcare engagement.
Together, we share a commitment to the clinical trial experience and to enhancing understanding and access for all, and we look forward to joining the Publicis Health network. Our mission remains unchanged, as does our commitment to supporting you in advancing your clinical R&D efforts.
Read More
Topics:
Most Viewed,
Joan F. Bachenheimer,
Publicis Health,
Alexandra von Plato